Stock listing

OTC:TRGNF Transgene SA Stock

US listing (OTC) of Transgene SA · home listing Euronext:TNG

Follow Transgene SA into a list and get an email when it puts out news.

Share price · OTC:TRGNF

$0.745 USD 0.000 (0.0%)

Close on Nov 6, 2026

Past year +6.4% · daily closes, Nov 6, 2025 – Nov 6, 2026, adjusted for splits
Day range
$0.745 – $0.745 USDNov 6, 2026
Market cap
$259.1M USDAt the close on Nov 6, 2026 · price × 347.8M shares outstanding
52-week range
$0.700 – $1.080 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
Traded on an average day
$20 USDMedian day 0 shares · 63 days with no trades · last 3 months, Aug 6, 2026 – Nov 6, 2026
Transgene SA logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:TNG · Home€0.715 EUR-0.006 (-0.8%)45,941€0.720€0.720€0.707€0.721Close on Nov 16, 2026
LSE:0OCQ€0.716 EUR-0.004 (-0.6%)99€0.722€0.722€0.716€0.720Close on Nov 16, 2026
OTC:TRGNF$0.745 USD0.000 (0.0%)—$0.745$0.745$0.745$0.745Close on Nov 6, 2026
Frankfurt:TGNA€0.694 EUR-0.012 (-1.7%)—€0.694€0.694€0.694€0.706Close on Nov 16, 2026

Daily closes

Last 3 months, Aug 6, 2026 – Nov 6, 2026 · OTC:TRGNF · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.7450.0000.0%$0.745$0.745$0.7450
$0.7450.0000.0%$0.745$0.745$0.7450
$0.7450.0000.0%$0.745$0.745$0.7450
$0.7450.0000.0%$0.745$0.745$0.7450
$0.7450.0000.0%$0.745$0.745$0.7450
$0.7450.0000.0%$0.745$0.745$0.7450
$0.7450.0000.0%$0.745$0.745$0.7450
$0.7450.0000.0%$0.745$0.745$0.7450
$0.7450.0000.0%$0.745$0.745$0.7450
$0.745-0.055-6.9%$0.745$0.745$0.745600
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8001,000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.8000.0000.0%$0.800$0.800$0.8000
$0.800-0.050-5.9%$0.800$0.800$0.800100
$0.8500.0000.0%$0.850$0.850$0.8500
$0.8500.0000.0%$0.850$0.850$0.8500
$0.8500.0000.0%$0.850$0.850$0.8500
$0.8500.0000.0%$0.850$0.850$0.8500
$0.8500.0000.0%$0.850$0.850$0.8500
$0.8500.0000.0%$0.850$0.850$0.8500

Splits

1 split · OTC:TRGNF · every price before a split is adjusted for it

DayRatioWhat
103-for-100Split
Ticker
OTC:TRGNF
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

What changed lately

Calls

Replays

  • Transgene (Euronext:TNG) Q4 2025 Earnings Call

    Tue, Mar 24, 2026 · 1:00 PM ET

    Watch Transcript
  • Transgene (Euronext:TNG) Q2 2025 Earnings Call

    Tue, Sep 16, 2025 · 12:00 PM ET

    Watch Transcript

Latest news

All Transgene SA news

Financings

  • Private placement of new ordinary shares

    Nov 25, 2025 · US$121.48M

    Update: about €105M · Van Lanschot Kempen NV +1

    Dealers: Van Lanschot Kempen NV (lead), Swiss Life Banque Privée (co-lead)

    Buyers: TSGH (irrevocably committed to subscribe for at least €70 million); Dassault Group (SITAM Belgium) (with another existing shareholder, intends to participate for €10 million)

    Use of proceeds: Accelerate the myvac individualized cancer vaccine program, R&D costs, and general and administrative expenses; cash runway to early 2028

    Announced Nov 25, 2025 · Update Nov 25, 2025

Read by 6ix AI from the company's releases

Decks

Transgene SA on 6ix

Sector
Health care
Industry
Biotechnology
News releases
36 in the last 12 months · 49 in all · newest Nov 9, 2026 · oldest 2025
Calls
2 calls with a replay · 2 with a transcript · latest Mar 24, 2026
Decks
66 decks · latest Sep 24, 2026

Where Transgene SA is listed

ListingExchangeCountryCurrency
Euronext:TNG · Home listingEuronextFranceEUR
gettex:TGNAgettexGermanyEUR
LSE:0OCQLSEUnited KingdomEUR
LS Exchange:913048LS ExchangeGermanyEUR
Lang & Schwarz:913048Lang & SchwarzGermanyEUR
Munich:TGNAMunichGermanyEUR
OTC:TRGNF · This pageOTCUnited StatesUSD
Frankfurt:TGNAFrankfurtGermanyEUR
Stuttgart:TGNAStuttgartGermanyEUR
Aquis:TNGPAquisUnited KingdomEUR
Aquis:TNGPAquisUnited KingdomEUR
Dusseldorf:TGNADusseldorfGermanyEUR
Hamburg:TGNAHamburgGermanyEUR
Turquoise:TNGPTurquoiseUnited KingdomEUR

Log in to ask 6ix AI your own questions about Transgene SA.